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Hans-Christian Slotved1* and Catherine Satzke2,3Abstract
Background: Although there are established methodologies for pneumococcal carriage studies, recent studies
have extended these by conducting a culture amplification step prior to pneumococcal identification or serotyping.
However, few data are available comparing the growth of different serotypes.
Findings: We compared the growth of individual isolates representing 23 serotypes in serum broth, and Todd-Hewitt
broth from four different manufacturers. Following overnight incubation of low inocula, there were differences in the
final growth densities of individual isolates. These can be minimised with the use of optimal media.
Conclusions: These data caution against using broth culture amplification of nasopharyngeal samples for some
applications.
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Streptococcus pneumoniae (the pneumococcus) is a major
cause of diseases such as pneumonia and meningitis,
particularly in developing countries. At present, more
than 90 immunologically-distinct capsular types have
been described [1]. Several vaccines targeting pneumo-
coccal capsular polysaccharide have been developed and
licensed with the aim of reducing pneumococcal disease
[2,3]. To monitor long-term vaccine effectiveness, it is
likely that countries will monitor invasive pneumococcal
disease and pneumonia [4,5], as well as changes to naso-
pharyngeal carriage, the latter being particularly relevant
for resource-poor settings [6]. There are standard
methods for assessing carriage [7], however broth cul-
ture amplification prior to pneumococcal identification
and/or serotyping has also been described [8,9]. Many
new methods, some of which are quantitative, are cap-
able of detecting multiple serotypes in a swab sample
[5]. However, the potential of different serotypes to grow
at different rates, and thereby reduce the ability to
accurately quantitate serotypes following culture amplifi-
cation, remains insufficiently studied [10].* Correspondence: hcs@ssi.dk
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distribution, and reproduction in any mediumA previous study on testing and evaluating a serological
test found that incubation in different growth media
resulted in different average final growth densities [11].
Given the increased focus on individual serotypes, the
current manuscript presents data from 23 different
pneumococcal isolates, representing each of the serotypes
in the current polysaccharide vaccine (23vPPS), following
overnight incubation in five different media: Todd Hewitt
(TH)-broth from four manufacturers (Oxoid, Sigma, Difco
and SSI Diagnostica) and serum broth (SSI Diagnostica).
Isolates (sourced from the Streptococcus Unit, Statens
Serum Institut, Denmark) were stored as lyophilized cul-
tures, or in nutrient beef broth with 10% glycerine (SSI
Diagnostica) at -80°C, and subcultured on 10% horse blood
agar plates (HBA, SSI Diagnostica) prior to use. To assess
growth, fresh overnight cultures of pneumococci (grown at
37°C in 5% CO2) were suspended in physiological saline
to a concentration of ~1 × 108 CFU/ml (Optical Density
(OD)540 = 0.28 measured by a colorimeter (Sherwood)). Fol-
lowing dilution in physiological saline, 30 μl was inoculated
into 3 ml broth (preheated to 37°C) resulting in a mean
starting concentration of 1.21 × 103 CFU/ml (95% CI:
7.09 × 102, 1.72 × 103 CFU/ml). Broths were incubated
overnight at 37°C in 5% CO2. Viable counts were then
conducted from serial dilution of a 100 μl aliquot in physio-
logical saline plated on HBA. Results are pooled data from
duplicate 18 and 24 h overnight incubations, resulting inentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Final growth densities of 23 isolates (representing each of the serotypes included in 23vPPS) following overnight incubation
(18 h, closed circles or 24 h, open circles) in serum broth (SSI) or TH-broth (SSI, Oxoid, Sigma, Difco) with a starting inocula of
approximately 1 × 103 CFU/ml. Horizontal lines are the mean +/- SD.
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Figure 2 Growth curves of 23 isolates (representing each of the serotypes included in 23vPPS) following incubation in serum broth
(SSI). 1 × 103 CFU/ml (50 μl) were inoculated into 250 μl pre-warmed broth in a microtitre plate, and then incubated at 37°C in 5% CO2. The
optical density (OD 630 nm) was measured every 15 min for 18 h using a spectrophotometer.
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missing data points spread across four media and four sero-
types. Data were analysed using ANOVA with Bonferroni’s
post-test or unpaired t-test as outlined below using
GraphPad Prism version 5.0.
Figure 1 depicts the density for each of the 23 different
pneumococcal isolates grown in five different broths fol-
lowing overnight incubation. As described in Slotved and
Kerrn [11], serum broth generally resulted in superior
growth compared with each of the TH-broths. Within
each media type there was a significant difference in the
final density of all serotypes using an ANOVA (p < 0.001),
the exception being Difco (p = 0.05). Bonferroni’s post-test
was used to compare the final growth densities between
pairs of individual isolates when grown in the same media
type. With serum broth, 10/253 (4%) of such comparisons
showed significant differences (p < 0.05). TH-broth (SSI,
Oxoid and Sigma) showed significant differences in 21,
8 and 69 (8%, 3% and 27%) of the 253 comparisons re-
spectively. For TH-broth (Difco) we did not find signifi-
cant differences in the growth of individual isolates, which
may be attributable to large variation in the final densities
for some serotypes. When we compared the individual
isolates in TH-broth (Difco) with small standard deviations
(SDs) (e.g. TP-1 versus TP-2, 4, 6B, 17F, 19F or TP-3 versus
TP-4) there were significant differences using an unpaired
t-test with Welch’s correction (p < 0.05), supporting this hy-
pothesis. We also observed that, in general, the final dens-
ities of isolates grown in serum broth were less variable
than when grown in the other media types.
To date, only a few studies have presented data showing
the growth and survival of pneumococci of differentserotypes in vitro [10,12-14]. Consistent with these, we
found media-dependent differences in the growth of indi-
vidual isolates representing 23 serotypes. Other studies
have found that the metabolic demands of production of
serotype-specific capsular polysaccharide can effect growth
in restricted media, and also found that a serotype 18C
strain showed a prolonged lag phase even in enriched
media [10,15].
To explore growth of the 23 isolates further, we
conducted preliminary growth curves in the five media
types. For each isolate a 2 × 108 CFU/ml physiological sa-
line solution was made (based on a measured OD value of
0.2 at 600 nm). From this solution a dilution of 1 × 103
CFU/ml was made, and 50 μl of this dilution was inocu-
lated into 250 μl pre-warmed broth in a microtitre plate.
Plates were incubated at 37°C in 5% CO2 and the optical
density (at 630 nm) measured every 15 min for approxi-
mately 18 h using a spectrophotometer. Growth curves
of some isolates differed. For example, in serum broth
(Figure 2) the final density ranged from 0.36 (serotype
17F) to 0.90 (serotype 9V), and the mid-log point occurred
at <10 h (serotype 19F) and ~15 h (serotype 3). Similar
variation in final density and mid-log point were seen with
the other media, although the lag time was generally lon-
ger, and as a result, lower final densities were observed
(data not shown).
One limitation of this study is that isolates from a strain
collection may have different growth characteristics than
carriage isolates. We did not elucidate the mechanism for
the observed differences in final growth densities (Figure 1).
However, it is likely that differences occur in all phases of
the growth curve, including in the levels of autolysis,
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ments could compare the growth characteristics of isolates
at shorter time-points, for example by conducting viable
counts after 4-6 h incubation.
Our results confirm that different pneumococcal iso-
lates grow to different densities in some media. On the
basis of these results, we recommend avoiding broth cul-
ture amplification steps that utilise overnight incubation
of nasopharyngeal samples prior to serotyping. Where
this cannot be avoided, an enriched growth medium
such as serum broth is likely to minimise the observed
growth differences between isolates.
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